|321.55||+6.89||+2.19%||Vol 3.05M||1Y Perf 66.50%|
|Jun 24th, 2022 16:04 DELAYED|
|- -||- -%|
|Target Price||360.33||Analyst Rating||Strong Buy 1.31|
|Potential %||12.06||Finscreener Ranking||☆ 33.94|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||☆ 32.62|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||+ 32.30|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||+ 26.50|
|Price Range Ratio 52W %||88.01||Earnings Rating||Strong Buy|
|Market Cap||46.17B||Earnings Date||3rd Aug 2022|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||3rd Aug 2022|
|Estimated EPS Next Report||5.29|
|EPS Growth Next 5 Years %||9.40|
|Avg. Weekly Volume||1.53M|
|Avg. Monthly Volume||1.14M|
|Avg. Quarterly Volume||1.15M|
McKesson Corporation (NYSE: MCK) stock closed at 321.55 per share at the end of the most recent trading day (a 2.19% change compared to the prior day closing price) with a volume of 3.05M shares and market capitalization of 46.17B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Distribution industry, Healthcare sector and employs 76000 people. McKesson Corporation CEO is Brian S. Tyler.
The one-year performance of McKesson Corporation stock is 66.5%, while year-to-date (YTD) performance is 29.36%. MCK stock has a five-year performance of 92.59%. Its 52-week range is between 186.61 and 339.94, which gives MCK stock a 52-week price range ratio of 88.01%
McKesson Corporation currently has a PE ratio of 41.90, a price-to-book (PB) ratio of 4.92, a price-to-sale (PS) ratio of 0.16, a price to cashflow ratio of 10.40, a PEG ratio of 2.32, a ROA of 1.74%, a ROC of -40.46% and a ROE of -97.17%. The company’s profit margin is 0.49%, its EBITDA margin is 1.10%, and its revenue ttm is $263.97 Billion , which makes it $1 838.45 revenue per share.
Of the last four earnings reports from McKesson Corporation, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $5.29 for the next earnings report. McKesson Corporation’s next earnings report date is 03rd Aug 2022.
The consensus rating of Wall Street analysts for McKesson Corporation is Strong Buy (1.31), with a target price of $360.33, which is +12.06% compared to the current price. The earnings rating for McKesson Corporation stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
McKesson Corporation has a dividend yield of 0.63% with a dividend per share of $1.88 and a payout ratio of 12.00%.
McKesson Corporation has a Buy technical analysis rating based on Technical Indicators (ADX : 8.20, ATR14 : 8.23, CCI20 : 22.20, Chaikin Money Flow : 0.18, MACD : -2.53, Money Flow Index : 50.24, ROC : -0.03, RSI : 55.56, STOCH (14,3) : 93.29, STOCH RSI : 1.00, UO : 65.64, Williams %R : -6.71), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of McKesson Corporation in the last 12-months were: Brian S. Tyler (Option Excercise at a value of $7 202 821), Brian S. Tyler (Sold 64 640 shares of value $18 593 112 ), Britt Vitalone (Option Excercise at a value of $4 710 594), Britt Vitalone (Sold 64 436 shares of value $17 436 558 ), Kevin W. Emerson (Sold 34 shares of value $8 348 ), Lori A. Schechter (Option Excercise at a value of $14 971 706), Lori A. Schechter (Sold 127 429 shares of value $31 772 889 ), Nancy Flores (Option Excercise at a value of $0), Nancy Flores (Sold 5 359 shares of value $1 712 018 ), Thomas L. Rodgers (Option Excercise at a value of $0), Thomas L. Rodgers (Sold 896 shares of value $293 002 ), Tracy Faber (Option Excercise at a value of $483 807), Tracy Faber (Sold 22 057 shares of value $6 255 217 )
Tue, 10 May 2022 05:37 GMT Analysts Offer Insights on Healthcare Companies: McKesson (MCK), Mednax (MD) and Moderna (MRNA)- TipRanks. All rights reserved.
Sat, 07 May 2022 12:19 GMT J.P. Morgan Believes McKesson (MCK) Wont Stop Here- TipRanks. All rights reserved.
Tue, 12 Apr 2022 16:35 GMT Analysts Offer Insights on Healthcare Companies: McKesson (MCK) and Innoviva (INVA)- TipRanks. All rights reserved.
Fri, 11 Feb 2022 10:04 GMT McKesson (MCK) Receives a Hold from Mizuho Securities- TipRanks. All rights reserved.
Sun, 23 Jan 2022 16:42 GMT Jefferies Believes McKesson (MCK) Wont Stop Here- TipRanks. All rights reserved.
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro. Your capital is at risk.
This could take some time, please wait.